Table 5. Age standardised cancer mortality ratios for CLL cohort.
|
Men
|
Women
|
Total
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Causes of mortality | O | SMR | 95% CI | O | SMR | 95% CI | O | SMR | 95% CI |
| All cancer deaths | 3368 | 5.99 | 5.79, 6.20 | 1974 | 7.15 | 6.84, 7.48 | 5342 | 6.81 | 6.63, 7.00 |
| All cancer deaths excluding LHNs | 882 | 1.72 | 1.61, 1.84 | 335 | 1.36 | 1.22, 1.51 | 1217 | 1.72 | 1.62, 1.82 |
| All LHNs | 2486 | 49.1 | 47.2, 51.1 | 1639 | 55.0 | 52.4, 57.8 | 4125 | 54.0 | 52.3, 55.6 |
| Colorectal cancer | 88 | 1.32 | 1.06, 1.62 | 47 | 1.15 | 0.84, 1.52 | 135 | 1.31 | 1.10, 1.55 |
| Lung cancer | 207 | 1.54 | 1.34, 1.77 | 60 | 1.62 | 1.23, 2.08 | 267 | 1.75 | 1.55, 1.98 |
| Breast cancer | 0 | — | — | 26 | 0.69 | 0.45, 1.01 | 26 | 0.69 | 0.45, 1.01 |
| Prostate cancer | 24 | 0.64 | 0.41, 0.95 | 0 | — | — | 24 | 0.64 | 0.41, 0.95 |
| All skin cancer | 186 | 8.28 | 7.13, 9.55 | 58 | 7.32 | 5.56, 9.46 | 244 | 8.89 | 7.81, 10.1 |
| Melanoma | 61 | 4.13 | 3.16, 5.31 | 26 | 4.94 | 3.23, 7.23 | 87 | 4.79 | 3.83, 5.90 |
| Non-melanoma skin cancer | 125 | 16.2 | 13.5, 19.3 | 32 | 12.0 | 8.22, 17.0 | 157 | 17.0 | 14.4, 19.8 |
| All non-cancer deaths | 1617 | 1.14 | 1.08, 1.19 | 1287 | 1.14 | 1.08, 1.20 | 2904 | 1.18 | 1.14, 1.23 |
| All causes | 4985 | 2.51 | 2.44, 2.59 | 3261 | 2.32 | 2.24, 2.40 | 8246 | 2.55 | 2.49, 2.60 |
Abbreviations: CI=confidence interval; CLL=chronic lymphocytic leukaemia; LHN=lymphohematopoetic neoplasm; O=observed; SIR=standardised mortality ratio.
Values in bold=95% CI did not include 1.00.